Magnetic Resonance Imaging in Radiotherapy for Breast Cancer

Recruiting now

Conditions studied: Breast Cancer

In brief

This is a single-center, prospective pilot study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatment (RT) for breast cancer.

Key facts

Study ID

NCT05902507

Run by

University of California, San Francisco

People needed

20

Starts

2023-05-15

Expected to finish

2027-05-31

Last updated by the study team

2026-06-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants with an Eastern Cooperative Oncology Group (ECOG) performance status <=2 (or Karnofsky ≥>=60%, see Appendix A).
• Participants with the ability to understand and the willingness to sign a written informed consent document.
• Participants may separately enroll on therapeutic clinical trials when they enroll on this trial. Note: All interventions on this protocol are standard of care, so enrollment on other therapeutic protocols is allowed at the discretion of the treating physician.
• Patients must have pathologically confirmed invasive or in situ breast cancer.
• Patients must have tumors in which adjuvant breast radiotherapy following breast conserving surgery is indicated, as determined by the treating physician.
• Patients must be female. Note: Male patients are excluded due to the rarity of male breast cancer and difficulty in pursuing breast conserving surgery for male patients.

You may not qualify if…

• Participants with a contraindication to MRI per the MRI checklist.
• Patients with breast tumor or tumor bed not visualized at CT or MRI during RT planning.

Where it is running

• University of California, San Francisco — San Francisco, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.